209 related articles for article (PubMed ID: 26147866)
21. Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia.
Lang K; Federico V; Muser E; Menzin J; Menzin J
J Med Econ; 2013 Aug; 16(8):997-1006. PubMed ID: 23777223
[TBL] [Abstract][Full Text] [Related]
22. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Value Health; 2009 Sep; 12(6):989-95. PubMed ID: 19402852
[TBL] [Abstract][Full Text] [Related]
23. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes.
Taber DJ; Ward R; Axon RN; Walker RJ; Egede LE; Gebregziabher M
Ann Pharmacother; 2019 Jul; 53(7):675-682. PubMed ID: 30724092
[TBL] [Abstract][Full Text] [Related]
25. Adherence to oral diabetes medications among users and nonusers of antipsychotic medication.
Desai PR; Adeyemi AO; Richards KM; Lawson KA
Psychiatr Serv; 2014 Feb; 65(2):215-20. PubMed ID: 24233254
[TBL] [Abstract][Full Text] [Related]
26. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
Cheong C; Barner JC; Lawson KA; Johnsrud MT
Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
[TBL] [Abstract][Full Text] [Related]
27. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
28. Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
Chang TE; Park S; Yang Q; Loustalot F; Butler J; Ritchey MD
PLoS One; 2019; 14(9):e0222868. PubMed ID: 31545830
[TBL] [Abstract][Full Text] [Related]
29. Do medical homes increase medication adherence for persons with multiple chronic conditions?
Beadles CA; Farley JF; Ellis AR; Lichstein JC; Morrissey JP; DuBard CA; Domino ME
Med Care; 2015 Feb; 53(2):168-76. PubMed ID: 25517069
[TBL] [Abstract][Full Text] [Related]
30. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
31. Medication adherence and improved outcomes among patients with type 2 diabetes.
Curtis SE; Boye KS; Lage MJ; Garcia-Perez LE
Am J Manag Care; 2017 Jul; 23(7):e208-e214. PubMed ID: 28850793
[TBL] [Abstract][Full Text] [Related]
32. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
An J; Nichol MB
Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
[TBL] [Abstract][Full Text] [Related]
33. Association Between Medication Adherence and the Outcomes of Heart Failure.
Hood SR; Giazzon AJ; Seamon G; Lane KA; Wang J; Eckert GJ; Tu W; Murray MD
Pharmacotherapy; 2018 May; 38(5):539-545. PubMed ID: 29600819
[TBL] [Abstract][Full Text] [Related]
34. Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.
Kim YY; Lee JS; Kang HJ; Park SM
Sci Rep; 2018 Aug; 8(1):12190. PubMed ID: 30111867
[TBL] [Abstract][Full Text] [Related]
35. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
[TBL] [Abstract][Full Text] [Related]
36. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
37. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences.
Simon-Tuval T; Shmueli A; Harman-Boehm I
Curr Med Res Opin; 2018 Feb; 34(2):345-351. PubMed ID: 29069921
[TBL] [Abstract][Full Text] [Related]
38. Survey nonresponders incurred higher medical utilization and lower medication adherence.
Rinne ST; Wong ES; Lemon JM; Perkins M; Bryson CL; Liu CF
Am J Manag Care; 2015 Jan; 21(1):e1-8. PubMed ID: 25880264
[TBL] [Abstract][Full Text] [Related]
39. Does medication adherence lead to lower healthcare expenses for patients with diabetes?
Cheng SH; Chen CC; Tseng CH
Am J Manag Care; 2013 Aug; 19(8):662-70. PubMed ID: 24304214
[TBL] [Abstract][Full Text] [Related]
40. Medicaid payment mechanisms: impact on medication adherence and health care service utilization in type 2 diabetes enrollees.
Pawaskar M; Burch S; Seiber E; Nahata M; Iaconi A; Balkrishnan R
Popul Health Manag; 2010 Aug; 13(4):209-18. PubMed ID: 20455787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
